MedTrace Logo

Early Diagnosis and Prognosis of Postoperative Sepsis by Presepsin and Syndecan-1

NCT04718623 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2021-01-22

No results posted yet for this study

Summary

The aim of the present work is to study: Persepsin (sCD-14) and Syndecan-1 as biomarkers following major surgeries for early diagnosis and prognosis of sepsis Primary aim: early diagnosis and prognosis of sepsis Secondary aim: correlate them with SOFA and qSOFA scores.

Conditions

  • Sepsis Following A Procedure
  • Diagnoses, Syndromes, and Conditions

Interventions

DIAGNOSTIC_TEST

Quantitative determination of serum Presepsin (sCD-14), and Syndecan-1 concentrations

Quantitative determination of serum Presepsin (sCD-14), and Syndecan-1 concentrations by ELISA technique

Sponsors & Collaborators

  • Alexandria University

    lead OTHER

Principal Investigators

  • Hesham F Shaaban, Prof · University of Alexandria

  • Rania Sh Swelem, Prof · University of Alexandria

  • Hussien W Hussein, PHD · University of Alexandria

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-28
Primary Completion
2022-03-31
Completion
2022-04-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04718623 on ClinicalTrials.gov